SUBSTITUTED CHROMANES AND METHOD OF USE

wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R″ have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WANG, Xueqing, KYM, Philip R, YEUNG, Ming C, VOIGHT, Eric, BOGDAN, Andrew, SEARLE, Xenia B, LIU, Bo, ALTENBACH, Robert J, KOENIG, John R, GRESZLER, Stephen N
Format: Patent
Sprache:eng ; hun
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WANG, Xueqing
KYM, Philip R
YEUNG, Ming C
VOIGHT, Eric
BOGDAN, Andrew
SEARLE, Xenia B
LIU, Bo
ALTENBACH, Robert J
KOENIG, John R
GRESZLER, Stephen N
description wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R″ have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE052373TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE052373TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE052373TT23</originalsourceid><addsrcrecordid>eNrjZFAPDnUKDvEMCQ1xdVFw9gjy93X0cw1WcPRzUfB1DfHwd1Hwd1MIDXblYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxHqGuBqZGxubGISFGxsSoAQD2iyRg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED CHROMANES AND METHOD OF USE</title><source>esp@cenet</source><creator>WANG, Xueqing ; KYM, Philip R ; YEUNG, Ming C ; VOIGHT, Eric ; BOGDAN, Andrew ; SEARLE, Xenia B ; LIU, Bo ; ALTENBACH, Robert J ; KOENIG, John R ; GRESZLER, Stephen N</creator><creatorcontrib>WANG, Xueqing ; KYM, Philip R ; YEUNG, Ming C ; VOIGHT, Eric ; BOGDAN, Andrew ; SEARLE, Xenia B ; LIU, Bo ; ALTENBACH, Robert J ; KOENIG, John R ; GRESZLER, Stephen N</creatorcontrib><description>wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R″ have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210428&amp;DB=EPODOC&amp;CC=HU&amp;NR=E052373T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210428&amp;DB=EPODOC&amp;CC=HU&amp;NR=E052373T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG, Xueqing</creatorcontrib><creatorcontrib>KYM, Philip R</creatorcontrib><creatorcontrib>YEUNG, Ming C</creatorcontrib><creatorcontrib>VOIGHT, Eric</creatorcontrib><creatorcontrib>BOGDAN, Andrew</creatorcontrib><creatorcontrib>SEARLE, Xenia B</creatorcontrib><creatorcontrib>LIU, Bo</creatorcontrib><creatorcontrib>ALTENBACH, Robert J</creatorcontrib><creatorcontrib>KOENIG, John R</creatorcontrib><creatorcontrib>GRESZLER, Stephen N</creatorcontrib><title>SUBSTITUTED CHROMANES AND METHOD OF USE</title><description>wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R″ have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAPDnUKDvEMCQ1xdVFw9gjy93X0cw1WcPRzUfB1DfHwd1Hwd1MIDXblYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxHqGuBqZGxubGISFGxsSoAQD2iyRg</recordid><startdate>20210428</startdate><enddate>20210428</enddate><creator>WANG, Xueqing</creator><creator>KYM, Philip R</creator><creator>YEUNG, Ming C</creator><creator>VOIGHT, Eric</creator><creator>BOGDAN, Andrew</creator><creator>SEARLE, Xenia B</creator><creator>LIU, Bo</creator><creator>ALTENBACH, Robert J</creator><creator>KOENIG, John R</creator><creator>GRESZLER, Stephen N</creator><scope>EVB</scope></search><sort><creationdate>20210428</creationdate><title>SUBSTITUTED CHROMANES AND METHOD OF USE</title><author>WANG, Xueqing ; KYM, Philip R ; YEUNG, Ming C ; VOIGHT, Eric ; BOGDAN, Andrew ; SEARLE, Xenia B ; LIU, Bo ; ALTENBACH, Robert J ; KOENIG, John R ; GRESZLER, Stephen N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE052373TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG, Xueqing</creatorcontrib><creatorcontrib>KYM, Philip R</creatorcontrib><creatorcontrib>YEUNG, Ming C</creatorcontrib><creatorcontrib>VOIGHT, Eric</creatorcontrib><creatorcontrib>BOGDAN, Andrew</creatorcontrib><creatorcontrib>SEARLE, Xenia B</creatorcontrib><creatorcontrib>LIU, Bo</creatorcontrib><creatorcontrib>ALTENBACH, Robert J</creatorcontrib><creatorcontrib>KOENIG, John R</creatorcontrib><creatorcontrib>GRESZLER, Stephen N</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG, Xueqing</au><au>KYM, Philip R</au><au>YEUNG, Ming C</au><au>VOIGHT, Eric</au><au>BOGDAN, Andrew</au><au>SEARLE, Xenia B</au><au>LIU, Bo</au><au>ALTENBACH, Robert J</au><au>KOENIG, John R</au><au>GRESZLER, Stephen N</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED CHROMANES AND METHOD OF USE</title><date>2021-04-28</date><risdate>2021</risdate><abstract>wherein R1, X, Y, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, m, and R″ have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sjögren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; hun
recordid cdi_epo_espacenet_HUE052373TT2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUBSTITUTED CHROMANES AND METHOD OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T14%3A37%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG,%20Xueqing&rft.date=2021-04-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE052373TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true